SCHEMBL14769561

SCHEMBL14769561

CC1(C)c2ccccc2-c2cc3c4cc(-c5ccc6c(c5)c5cc7c(cc5n6-c5nc(-c6ccccc6)nc(-c6cccc(-c8cccc(-c9cc(-c%10ccccc%10)cc(-c%10ccccc%10)c9)c8)c6)n5)C(C)(C)c5ccccc5-7)ccc4n(-c4nc(-c5ccccc5)nc(-c5cccc(-c6cccc(-c7cc(-c8ccccc8)cc(-c8ccccc8)c7)c6)c5)n4)c3cc21

nearest known ligand 0.30

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 2/20 0.30
▸ ALDH1A1 P00352 2/20 0.30
▸ MAPT P10636 2/20 0.30
▸ HPGD P15428 2/20 0.30
▸ KMT2A Q03164 2/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12181442 1.00 MEN1 (0.30) MEN1ALDH1A1MAPTHPGDKMT2A
SCHEMBL802112 0.99 PDK2 (0.30) —
SCHEMBL802641 0.99 MEN1 (0.31) MEN1ALDH1A1MAPTHPGDKMT2A
SCHEMBL802689 0.98 MEN1 (0.32) MEN1ALDH1A1MAPTHPGDKMT2A
SCHEMBL20408493 0.98 MEN1 (0.32) MEN1ALDH1A1MAPTHPGDKMT2A
SCHEMBL802692 0.98 PDK2 (0.30) —
SCHEMBL802543 0.96 PDK2 (0.30) —
SCHEMBL802650 0.96 PDK2 (0.30) —
SCHEMBL782089 0.96 MEN1 (0.33) MEN1ALDH1A1MAPTHPGDKMT2A
SCHEMBL802996 0.96 MEN1 (0.33) MEN1ALDH1A1MAPTHPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3323159-B1 COMPOSITION COMPRISING ORGANIC SEMICONDUCTING COMPOUNDS MERCK PATENT GMBH (DE) 2023-01-04 — — EP disclosed
US-10714691-B2 Formulations for the production of electronic devices MERCK PATENT GMBH (DE) 2020-07-14 — — US disclosed
US-20190207114-A9 FORMULATIONS AND ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2019-07-04 — — US disclosed
US-20180212166-A1 COMPOSITION COMPRISING ORGANIC SEMICONDUCTING COMPOUNDS MERCK PATENT GMBH (DE) 2018-07-26 — — US disclosed
US-20180212166-A1 COMPOSITION COMPRISING ORGANIC SEMICONDUCTING COMPOUNDS MERCK PATENT GMBH (DE) 2018-07-26 — — US disclosed
US-20180114912-A1 FORMULATIONS AND ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-04-26 — — US disclosed
US-20180114912-A1 FORMULATIONS AND ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2018-04-26 — — US disclosed
US-9882135-B2 Formulations and electronic devices MERCK PATENT GMBH (DE) 2018-01-30 — — US disclosed
US-9882135-B2 Formulations and electronic devices MERCK PATENT GMBH (DE) 2018-01-30 — — US disclosed
US-9666806-B2 Formulations for the production of electronic devices MERCK PATENT GMBH (DE) 2017-05-30 — — US disclosed
US-20150364689-A1 FORMULATIONS AND ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-12-17 — — US disclosed
US-20150364689-A1 FORMULATIONS AND ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2015-12-17 — — US disclosed
US-9159930-B2 Formulations and electronic devices MERCK PATENT GMBH (DE) 2015-10-13 — — US disclosed
US-9159930-B2 Formulations and electronic devices MERCK PATENT GMBH (DE) 2015-10-13 — — US disclosed
US-8974702-B2 Composition for the preparation of organic electronic (OE) devices MERCK PATENT GMBH (DE) 2015-03-10 — — US disclosed
US-8974702-B2 Composition for the preparation of organic electronic (OE) devices MERCK PATENT GMBH (DE) 2015-03-10 — — US disclosed
US-20140048745-A1 FORMULATIONS AND ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2014-02-20 — — US disclosed
US-20140048745-A1 FORMULATIONS AND ELECTRONIC DEVICES MERCK PATENT GMBH (DE) 2014-02-20 — — US disclosed
US-20130062581-A1 COMPOSITION FOR THE PREPARATION OF ORGANIC ELECTRONIC (OE) DEVICES MERCK PATENT GMBH (DE) 2013-03-14 — — US disclosed
US-20130062581-A1 COMPOSITION FOR THE PREPARATION OF ORGANIC ELECTRONIC (OE) DEVICES MERCK PATENT GMBH (DE) 2013-03-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180114912-A1 FORMULATIONS AND ELECTRONIC DEVICES SLC19A1, IK, KCNQ2 MEN1 1729/4885ALDH1A1 1630/4885MAPT 1106/4885
US-20190207114-A9 FORMULATIONS AND ELECTRONIC DEVICES SLC19A1, IK, KCNQ2 MEN1 1729/4885ALDH1A1 1630/4885MAPT 1106/4885
US-10714691-B2 Formulations for the production of electronic devices NR3C2, KCNE1, NR2E1 MEN1 2023/4885ALDH1A1 1674/4885MAPT 4347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback